BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

Overview

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is the #20 most commonly reported adverse reaction for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, manufactured by INDIVIOR INC.. There are 791 FDA adverse event reports linking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE to WRONG TECHNIQUE IN PRODUCT USAGE PROCESS. This represents approximately 1.3% of all 59,605 adverse event reports for this drug.

Patients taking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE who experience wrong technique in product usage process should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS is a less commonly reported adverse event for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, but still significant enough to appear in the safety profile.

Other Side Effects of BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE

In addition to wrong technique in product usage process, the following adverse reactions have been reported for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE:

• DRUG DEPENDENCE — 4,275 reports
• DRUG WITHDRAWAL SYNDROME — 3,327 reports
• PAIN — 2,543 reports
• OFF LABEL USE — 2,061 reports
• OVERDOSE — 1,850 reports
• NAUSEA — 1,627 reports
• EMOTIONAL DISTRESS — 1,472 reports
• ANXIETY — 1,348 reports
• VOMITING — 1,336 reports
• HEADACHE — 1,109 reports

Other Drugs Associated with WRONG TECHNIQUE IN PRODUCT USAGE PROCESS

The following drugs have also been linked to wrong technique in product usage process in FDA adverse event reports:

Does BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE cause WRONG TECHNIQUE IN PRODUCT USAGE PROCESS?

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS has been reported as an adverse event in 791 FDA reports for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is WRONG TECHNIQUE IN PRODUCT USAGE PROCESS with BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE?

WRONG TECHNIQUE IN PRODUCT USAGE PROCESS accounts for approximately 1.3% of all adverse event reports for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, making it a notable side effect.

What should I do if I experience WRONG TECHNIQUE IN PRODUCT USAGE PROCESS while taking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE?

If you experience wrong technique in product usage process while taking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages